897665-80-4Relevant academic research and scientific papers
Copper-catalyzed acylation of pyrazolones with aldehydes to afford 4-acylpyrazolones
Xiao, Yan,Wu, Xiaopeng,Teng, Jiangang,Sun, Song,Yu, Jin-Tao,Cheng, Jiang
, p. 7552 - 7557 (2019)
Copper-catalyzed direct acylation of the alkenyl C-H bond in 1,2-dihydro-3H-pyrazol-3-ones has been developed, affording a series of 4-acylpyrazolones in moderate to good yields. Notably, this protocol involves readily accessible substrates and reagents, which have good functional group tolerance leading to pyrazolone derivatives under mild reaction conditions.
SCREENING METHODS AND THERAPEUTIC APPLICATIONS BASED ON BACTERIAL MOTILITY INHIBITION
-
Paragraph 0239-0244; 0249-0252, (2021/10/15)
The present invention relates to compounds for use in treating and/or preventing a bacterial infection or a condition associated with the bacterial infection, wherein the bacterial infection is caused by flagellated bacteria. The present invention further relates to a method of identifying compounds having bacterial anti-motility activity.
PYRAZOLONE COMPOUNDS AS METABOTROPIC GLUTAMATE RECEPTOR AGONISTS FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS
-
Page/Page column 52; 53, (2008/06/13)
Compounds of Formula (I), wherein R1, R2, R3, R4, R5, R6, X, and n are as defined for Formula (I) in the description, processes for the preparation of the compounds and new intermediates employed in the preparation, pharmaceutical compositions containing the compounds, and the use of the compounds in the treatment or prevention of neurological and psychiatric disorders associated with glutamate dysfunction.
